Proteome Sciences (LON:PRM) Shares Down 26.4% – Here’s What Happened

Shares of Proteome Sciences plc (LON:PRM) were down 26.4% during mid-day trading on Monday. The company traded as low as GBX 1.24 and last traded at GBX 1.24. Approximately 50,059 shares traded hands during mid-day trading, a decline of 86% from the average daily volume of 350,652 shares. The stock had previously closed at GBX 1.69.

Proteome Sciences Trading Down 26.4%

The company has a 50 day moving average of GBX 1.48 and a 200 day moving average of GBX 1.69. The firm has a market cap of £4.36 million, a P/E ratio of -1.73 and a beta of 0.16. The company has a debt-to-equity ratio of -161.07, a quick ratio of 0.37 and a current ratio of 0.12.

Proteome Sciences (LON:PRM) last released its quarterly earnings results on Wednesday, September 16th. The company reported GBX (0.41) earnings per share for the quarter. Proteome Sciences had a negative net margin of 61.46% and a positive return on equity of 23.85%.

About Proteome Sciences

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.